HOONMO KOO to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications HOONMO KOO has written about Randomized Controlled Trials as Topic.
Connection Strength
0.074
-
Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol. 2010 Jan; 26(1):17-25.
Score: 0.059
-
Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance. Expert Rev Anti Infect Ther. 2010 May; 8(5):555-64.
Score: 0.015